Ho Joon Im
Overview
Explore the profile of Ho Joon Im including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
978
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koh Y, Yoon S, Kang S, Koh K, Im H, Kim H
Br J Haematol
. 2025 Feb;
PMID: 39957044
No abstract available.
2.
Yoon S, Kang S, Kim H, Choi E, Im H, Koh K
Bone Marrow Transplant
. 2025 Jan;
PMID: 39815034
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication in hematopoietic cell transplantation (HCT). Given the rarity of prospective pediatric studies on TA-TMA, this study aimed to evaluate the incidence,...
3.
Koh K, Jun H, Lee J, Kim J, Yoon S, Koh Y, et al.
Cancer Res Treat
. 2024 Dec;
PMID: 39727013
Purpose: This study aimed to conduct a comprehensive genetic analysis of patients with Langerhans cell histiocytosis (LCH), focusing on the frequency of MAPK pathway mutations, detailed mutation profiles of MAPK...
4.
Park J, Song J, Yoo R, Kim D, Chun M, Han J, et al.
J Pediatr Hematol Oncol
. 2024 Dec;
47(1):12-18.
PMID: 39641618
Objectives: This study aimed to develop machine learning (ML) prediction models for identifying bloodstream infection (BSI) and septic shock (SS) in pediatric patients with cancer who presenting febrile neutropenia (FN)...
5.
Yoon Choi J, Kwon H, Kim H, Hong K, Ma Y, Koh K, et al.
Front Pharmacol
. 2024 Nov;
15:1480657.
PMID: 39611166
Background: Methotrexate (MTX) is the primary drug used in the treatment of pediatric acute lymphoblastic leukemia (ALL). However, some patients exhibit delayed clearance of high-dose (HD) MTX, which induces severe...
6.
Locatelli F, Antmen B, Kang H, Koh K, Takahashi Y, Kupesiz A, et al.
Lancet Haematol
. 2024 Jul;
11(8):e580-e592.
PMID: 39002551
Background: Chronic graft-versus-host disease (GVHD) is a debilitating, and sometimes life threatening, complication of allogeneic haematopoietic stem-cell transplantation (HSCT). We aimed to investigate the activity, pharmacokinetics, and safety of ruxolitinib...
7.
Koh K, Yoon S, Kang S, Kim H, Im H
Blood Res
. 2024 Jul;
59(1):22.
PMID: 38963520
Histiocytic neoplasms are rare diseases involving macrophages, dendritic cells, and monocytes. They include Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), Rosai-Dorfman disease (RDD), juvenile xanthogranuloma (JXG), and histiocytic sarcoma. Histiocytic...
8.
Jang J, Park J, Kim Y, Im H, Koh K, Kim H, et al.
Turk J Pediatr
. 2024 Mar;
66(1):99-109.
PMID: 38523384
Background: Intensive multimodal treatment can improve survival in patients with high-risk neuroblastoma, and consolidative radiation therapy has contributed to local control. We examined the clinical outcomes of patients who underwent...
9.
Hwang S, Lee Y, Yoon J, Kim J, Kim H, Koh K, et al.
Ann Pediatr Endocrinol Metab
. 2024 Jan;
29(2):109-118.
PMID: 38271994
Purpose: As the survival rate from pediatric cancers has increased significantly with advances in treatment modalities, long-term endocrine complications have also risen. This study investigated the frequencies and risks of...
10.
Seo E, Choi E, Kim J, Kim H, Koh K, Im H, et al.
PLoS One
. 2023 Nov;
18(11):e0294486.
PMID: 37956185
[This corrects the article DOI: 10.1371/journal.pone.0246191.].